Holen Sie sich die Stockscreener-App
2.925
5.02%
-0.165
Schlusskurs vom Vortag:
$3.09
Offen:
$3.1
24-Stunden-Volumen:
442.94K
Relative Volume:
0.80
Marktkapitalisierung:
$210.54M
Einnahmen:
$115.02M
Nettoeinkommen (Verlust:
$-68.73M
KGV:
-3.126
EPS:
-0.9357
Netto-Cashflow:
$-53.22M
1W Leistung:
-7.99%
1M Leistung:
+6.73%
6M Leistung:
-11.33%
1J Leistung:
-13.93%
1-Tages-Spanne:
$2.93
$3.1499
1-Wochen-Bereich:
$2.93
$3.23
52-Wochen-Spanne:
$2.08
$4.22
Orasure Technologies Inc Stock (OSUR) Company Profile
Firmenname
Orasure Technologies Inc
Sektor
Telefon
(503) 641-6115
Adresse
220 E FIRST ST, BETHLEHEM, PA
Compare OSUR vs ISRG, BDX, ALC, RMD, MDLN
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OSUR
Orasure Technologies Inc
|
2.935 | 221.66M | 115.02M | -68.73M | -53.22M | -0.9357 |
|
ISRG
Intuitive Surgical Inc
|
471.86 | 170.20B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
160.02 | 45.41B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
77.13 | 38.26B | 10.40B | 980.00M | 1.61B | 1.9749 |
|
RMD
Resmed Inc
|
231.74 | 33.86B | 5.40B | 1.49B | 1.78B | 10.12 |
|
MDLN
Medline Inc
|
41.46 | 33.33B | 28.43B | 1.16B | 1.26B | 1.4457 |
Orasure Technologies Inc Stock (OSUR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-01-03 | Fortgesetzt | Evercore ISI | In-line |
| 2021-09-22 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2020-08-21 | Eingeleitet | Evercore ISI | Outperform |
| 2020-08-10 | Eingeleitet | Citigroup | Buy |
| 2020-08-10 | Eingeleitet | JP Morgan | Neutral |
| 2020-08-07 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2020-06-25 | Eingeleitet | Lake Street | Buy |
| 2020-04-21 | Fortgesetzt | Stephens | Equal-Weight |
| 2018-10-23 | Fortgesetzt | Raymond James | Mkt Perform |
| 2018-07-16 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2017-11-02 | Herabstufung | Jefferies | Buy → Hold |
| 2017-02-09 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2016-06-13 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2015-11-05 | Bestätigt | Mizuho | Buy |
| 2015-05-07 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2015-01-23 | Bestätigt | Mizuho | Buy |
| 2014-06-12 | Bestätigt | Canaccord Genuity | Buy |
| 2014-06-11 | Bestätigt | Mizuho | Buy |
| 2012-12-21 | Eingeleitet | Mizuho | Buy |
| 2012-08-08 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2012-07-05 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2012-03-27 | Eingeleitet | JMP Securities | Mkt Outperform |
Alle ansehen
Orasure Technologies Inc Aktie (OSUR) Neueste Nachrichten
Aug Fed Impact: Is OraSure Technologies Inc attractive for institutional investorsExit Point & Daily Volume Surge Signals - baoquankhu1.vn
Former VA head departs OraSure board - WFMZ.com
OraSure Technologies 2025 Annual Report: Diagnostic Products, Genomic Solutions, and Global Expansion - Minichart
Momentum Shift: Is OraSure Technologies Inc being accumulated by smart moneyWeekly Trade Review & Expert Verified Movement Alerts - baoquankhu1.vn
Fed Meeting: Why is OraSure Technologies Inc stock going upJuly 2025 Gainers & Long Hold Capital Preservation Plans - baoquankhu1.vn
OraSure Technologies (NASDAQ:OSUR) Stock Price Crosses Above 200 Day Moving AverageHere's What Happened - MarketBeat
OraSure Technologies Developments Capture Healthcare Market Interest - Kalkine Media
OraSure Technologies Announces Resignation of Board Member Shulkin - TipRanks
OraSure (OSUR) CEO gets major stock awards, shares withheld for taxes - Stock Titan
OraSure Technologies, Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:OSUR) 2026-03-03 - Seeking Alpha
Healthy Trucking Association Launches Hepatitis C Initiative - Heavy Duty Trucking
OSUR Should I Buy - Intellectia AI
OraSure Technologies, Inc. (NASDAQ:OSUR) Q4 2025 Earnings Call Transcript - Insider Monkey
OraSure Technologies (OSUR) Loss Worsens To US$0.27 EPS And Tests Margin Recovery Narrative - simplywall.st
OraSure Technologies, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
OraSure Announces Fourth Quarter 2025 Financial Results - National Today
OraSure Technologies Q4 Earnings Call Highlights - MarketBeat
OraSure Technologies Inc (OSUR) Q4 2025 Earnings Call Highlights - GuruFocus
OraSure signals revenue ramp in H2 2026 with two FDA-submitted diagnostics launches - MSN
Earnings Call Summary | OraSure Technologies(OSUR.US) Q4 2025 Earnings Conference - 富途牛牛
OraSure: Fourth Quarter Financial Results Overview - Bitget
OraSure Technologies Inc reports results for the quarter ended September 30Earnings Summary - TradingView
OraSure closes the book on 'transition year' of 2025 - WFMZ.com
Earnings call transcript: OraSure Technologies Q4 2025 earnings fall short of revenue expectations - Investing.com Australia
OraSure Technologies (NASDAQ:OSUR) Releases Earnings Results, Misses Expectations By $0.04 EPS - MarketBeat
OraSure: Q4 Earnings Snapshot - Barchart.com
OraSure Technologies (OSUR) Stock Falls on Q4 2025 Earnings - Quiver Quantitative
OraSure Highlights 2025 Results and 2026 Growth Outlook - TipRanks
Revenue drops as OraSure (NASDAQ: OSUR) posts deeper 2025 loss - Stock Titan
Tranche Update on OraSure Technologies, Inc.'s Equity Buyback Plan announced on March 24, 2025. - marketscreener.com
OraSure Technologies Inc expected to post a loss of 20 cents a shareEarnings Preview - TradingView
OraSure Technologies (OSUR) Expected to Announce Earnings on Wednesday - MarketBeat
Aug Technicals: Can Fulgent Genetics Inc stock outperform in a bear marketQuarterly Investment Review & Free Daily Entry Point Trade Alerts - baoquankhu1.vn
OraSure’s HIV self-test receives Health Canada license By Investing.com - Investing.com Nigeria
OraSure Technologies (NASDAQ:OSUR) Stock Price Crosses Above Two Hundred Day Moving AverageHere's What Happened - MarketBeat
OraSure makes job cuts as it ‘rebalances’ for future growth - Lehigh Valley Business
How sensitive is OraSure Technologies Inc. to inflationJuly 2025 Setups & Verified Chart Pattern Signals - mfd.ru
Will OraSure Technologies Inc. stock benefit from automationJuly 2025 Final Week & Weekly High Potential Alerts - mfd.ru
Oral HIV self-test approved for sale in Canada - CBC
Oral HIV self-test can now be sold in Canada in ‘key’ move - Global News
Canada’s first oral HIV self-test has been approved for sale - The Globe and Mail
OraSure (OSUR) Gains Health Canada Approval for OraQuick HIV Sel - GuruFocus
Orasure to Launch Oraquick?? Hiv Self-Test in Canada - marketscreener.com
OraSure’s HIV self-test receives Health Canada license - Investing.com
OraSure to Launch OraQuick™ HIV Self-Test in Canada - ChartMill
OraSure to Announce Fourth Quarter 2025 Financial Results and Host Earnings Call on February 25th - The Manila Times
OraSure Technologies, Inc. Schedules Fourth Quarter 2025 Earnings Conference Call for February 25, 2026 - Quiver Quantitative
OraSure trimming global workforce, including here in Lehigh Valley - WFMZ.com
Treasury Yields: How does OraSure Technologies Inc perform in inflationary periodsJuly 2025 Spike Watch & Smart Allocation Stock Reports - baoquankhu1.vn
OraSure Technologies (NASDAQ:OSUR) Share Price Passes Above 200 Day Moving AverageWhat's Next? - MarketBeat
OTC/DTC Infectious Disease Diagnostics Research Report 2026: Market Strategies, Trends, and Forecasts 2025-2029 - GlobeNewswire Inc.
Finanzdaten der Orasure Technologies Inc-Aktie (OSUR)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.05%
0.01%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):